Abstract
Among the respiratory viruses circulating around the world, the human Respiratory Syncytial Virus (hRSV) stands out, one of the most common pathological agents of acute respiratory infections in newborns, children, and elderly. To date, there is no vaccine for newborns and children approved in Brazil and the only licensed treatment commonly offered, a monoclonal antibody targeting the vir…